Alfred Luitjens | Director Cell Technology at Batavia Biosciences
Batavia Biosciences

Alfred Luitjens, Director Cell Technology at Batavia Biosciences, Batavia Biosciences

Alfred Luitjens is the Director Cell Technology at Batavia Biosciences. He has a profound background in development and production of vaccines, with more than 30 years of experience. He worked for research & development at Solvay, DSM Biologics and Crucell. He had a management position at the Animal Science Group and was senior manager process architecture at GSK. At Batavia Biosciences Alfred is leading all upstream development vaccine projects.

Appearances:



Day Two 11th October, Human @ 15:15

How Innovative Process Development Allows for a Novel Cost-effective Rotavirus Vaccine

The development of novel technologies within biotechnology is highly dynamic, but implementation of these innovations into a manufacturing process stays behind. Three novel technologies are linked to create a simple, but robust, automated vaccine manufacturing platform that can deliver high yields at low cost. The technology platform links mammalian cell lines used for vaccine production in a compact, high cell density bioreactor, and affinity purification into a cost effective automated vaccine manufacturing system in a self-contained miniaturized facility. Polio vaccine production will be used to showcase the new miniaturized production system.
 

back to speakers